Hematology TimesGeneric azacitidine approved in CanadaNovember 16, 2017AnemiaLeukemia, Myelodysplasia, TransplantationPharmacyAMLMyelodysplastic Syndrome
Oncology PracticeCancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareCMLGastroenterologyLeukemia, Myelodysplasia, TransplantationALLLung CancerRenal Cell Carcinoma
Hematology NewsDebate: Is MRD ready for prime time in multiple myeloma?November 15, 2017Multiple MyelomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticeNCI-MATCH: Nivolumab shows promising activity in noncolorectal cancersNovember 15, 2017Immuno-oncologyAggressive LymphomasGynecologic CancerGenitourinary CancerBreast Cancer
Hematology TimesRestrictive transfusion method safe in cardiac surgery patientsNovember 15, 2017Blood Banking
Hematology TimesParity laws don’t lower oral cancer drug costs for everyoneNovember 15, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Oncology PracticeGut bacteria influenced response to checkpoint inhibitorsNovember 14, 2017Immuno-oncologyMelanomaLung CancerGenitourinary Cancer
Hematology NewsVIDEO: U.S. hypertension guidelines reset threshold to 130/80 mm HgNovember 14, 2017Thrombosis
Hematology NewsFDA approves dasatinib for pediatric Ph+ CMLNovember 14, 2017CMLLeukemia, Myelodysplasia, Transplantation
Oncology PracticeThe better mammogram: Experts explore sensitivity of new modalitiesNovember 14, 2017Breast CancerPreventive Care
Hematology NewsTargeting PCSK9 inhibitors to reap most benefitNovember 14, 2017Preventive CareThrombosis
